They did meet with the FDA following the Saudi trial so you would think they would have known then that the study would not be sufficient for approval but its impossible to know for sure what kind of dialogue went on between them.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.